« Back to Research Deepdives

Insulin Sensitising Drugs & Nutrients for PCOS

This content is restricted to members.

To view our premium content, sign up for a membership:


Register New Account

Choose your membership level

Choose Your Payment Method

‹ Back to Research Deepdives


1. Kayampilly P, Wanamaker B, Stewart J, Wagner C, Menon K. Stimulatory Effect of Insulin on 5α-Reductase Type 1 (SRD5A1) Expression through an Akt-Dependent Pathway in Ovarian Granulosa Cells. Endocrinology. 2010;151(10):5030-5037.
2. Diamanti-Kandarakis E, Economou F, Palimeri S, Christakou C. Metformin in polycystic ovary syndrome. Annals of the New York Academy of Sciences. 2010;1205(1):192-198.
3. Froment P, Touraine P. Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS). PPAR Research. 2006;2006:1-8.
4. Lepore E, Lauretta R, Bianchini M, Mormando M, Di Lorenzo C, Unfer V. Inositols Depletion and Resistance: Principal Mechanisms and Therapeutic Strategies. International Journal of Molecular Sciences. 2021;22(13):6796.
5. Unfer V, Porcaro G. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Review of Clinical Pharmacology. 2014;7(5):623-631.
6. Iuorno M, Jakubowicz D, Baillargeon J, Dillon P, Gunn R, Allan G et al. Effects of D-Chiro-Inositol in Lean Women with the Polycystic Ovary Syndrome. Endocrine Practice. 2002;8(6):417-423.
7. Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H et al. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. European Journal of Endocrinology. 2012;166(1):99-105.
8. Pizzo A, Laganà A, Barbaro L. Comparison between effects of myo-inositol andd-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecological Endocrinology. 2013;30(3):205-208.
9. Baillargeon J, Iuorno M, Jakubowicz D, Apridonidze T, He N, Nestler J. Metformin Therapy Increases Insulin-Stimulated Release ofd-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2004;89(1):242-249.
10. Abu Hashim H, Anwar K, El-Fatah R. N-Acetyl Cysteine Plus Clomiphene Citrate Versus Metformin and Clomiphene Citrate in Treatment of Clomiphene-Resistant Polycystic Ovary Syndrome: A Randomized Controlled Trial. Journal of Women’s Health. 2010;19(11):2043-2048.
11. Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, Mahmoodi S, Taghizadeh M et al. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Experimental and Clinical Endocrinology & Diabetes. 2017;126(04):222-228.
12. Gower B, Chandler-Laney P, Ovalle F, Goree L, Azziz R, Desmond R et al. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clinical Endocrinology. 2013;79(4):550-557.
13. Goss A, Chandler-Laney P, Ovalle F, Goree L, Azziz R, Desmond R et al. Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism. 2014;63(10):1257-1264.